Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo

Neoplasia

Volumn 11, Issue 1, 2009, Pages 77-86

  Kolesnikova, Tatiana V ^a,b   Kazarov, Alexander R ^a,b   Lemieux, Madeleine E ^a,b   Lafleur, Marc A ^a,b   Kesari, Santosh ^a,c   Kung, Andrew L ^a,b   Hemler, Martin E ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CD81 ANTIGEN; CD9 ANTIGEN; CELL SURFACE IMMUNOGLOBULIN; GELATINASE A; MATRIX METALLOPROTEINASE 14; PROTEIN EWI 2; TETRASPANIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 58249120108     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.81180     Document Type: Article

References (59)

1. Brain Tumor Invasion. Biological, Clinical, and Therapeutic Considerations. In T Mikkelsen, R Bjerkvig, OD Laerum, ML Rosenblum (Eds). ISBN: 978-0-471-15452-5.
2. Stipp CS, Kolesnikova TV, and Hemler ME (2001). EWI-2 is a major CD9 and CD81 partner, and member of a novel Ig protein subfamily. J Biol Chem 276, 40545-40554.
3. Kolesnikova TV, Stipp CS, Rao RM, Lane WS, Luscinskas FW, and Hemler ME (2004). EWI-2 modulates lymphocyte integrin alpha4beta1 functions. Blood 103, 3013-3019.
4. Stipp CS, Kolesnikova TV, and Hemler ME (2003). EWI-2 regulates {alpha}3{beta}1 integrin-dependent cell functions on laminin-5. J Cell Biol 163, 1167-1177.
5. Zhang XA, Lane WS, Charrin S, Rubinstein E, and Liu L (2003). EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. Cancer Res 63, 2665-2674.
6. Kawashima M, Doh-ura K, Mekada E, Fukui M, and Iwaki T (2002). CD9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumors. J Histochem Cytochem 50, 1195-1203.
7. Kelic S, Levy S, Suarez C, and Weinstein DE (2001). CD81 regulates neuron-induced astrocyte cell-cycle exit. Mol Cell Neurosci 17, 551-560.
8. Geisert EE Jr, Williams RW, Geisert GR, Fan L, Asbury AM, Maecker HT, Deng J, and Levy S (2002). Increased brain size and glial cell number in CD81-null mice. J Comp Neurol 453, 22-32.
9. 1 at cell-cell contact sites. J Cell Biol 129, 1691-1705.
10. Shi W, Fan H, Shum L, and Derynck R (2000). The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol 148, 591-602.
11. Mishima K, Higashiyama S, Asai A, Yamaoka K, Nagashima Y, Taniguchi N, Kitanaka C, Kirino T, and Kuchino Y (1998). Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol 96, 322-328.
12. Rubenstein M, Glick R, Lichtor T, Mirochnik Y, Chou P, and Guinan P (2001). Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor. Med Oncol 18, 121-130.
13. Hemler ME (2003). Tetraspanin proteins mediate cellular penetration, invasion and fusion events, and define a novel type of membrane microdomain. Ann Rev Cell Dev Biol 19, 397-422.
14. Maecker HT, Todd SC, and Levy S (1997). The tetraspanin superfamily: molecular facilitators. FASEB J 11, 428-442.
15. Hemler ME (2005). Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6, 801-811.
16. Le Naour F, Andre M, Greco C, Billard M, Sordat B, Emile JF, Lanza F, Boucheix C, and Rubinstein E (2006). Profiling of the tetraspanin web of human colon cancer cells. Mol Cell Proteomics 5, 845-857.
17. Yang XH, Kovalenko OV, Kolesnikova TV, Andzelm MM, Rubinstein E, Strominger JL, and Hemler ME (2006). Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. J Biol Chem 281, 12976-12985.
18. Charrin S, Le Naour F, Labas V, Billard M, Le Caer JP, Emile JF, Petit MA, Boucheix C, and Rubinstein E (2003). EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J 373 (Pt 2), 409-421.
19. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, et al. (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA 102, 5814-5819.
20. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9, 287-300.
21. 6-alkylating agents in human glioblastomas. J Clin Oncol 24, 274-287.
22. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, and Sikic BI (2005). Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65, 8679-8689.
23. Pear W, Nolan G, Scott M, and Baltimore D (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90, 8392-8396.
24. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, and Segal RA (2003). A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100, 13513-13518.
25. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, and Hemler ME (2004). Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol 167, 1231-1240.
26. Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, and James CD (2005). Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol 7, 164-176.
27. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, and Dirks PB (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401.
28. Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, Bachoo RM, Kane M, Louis DN, DePinho RA, et al. (2007). Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53, 503-517.
29. Murdoch J, Doudney K, Gerrelli D, Wartham N, Patermott C, Stanier P, and Copp A (2003). Genomic organization and embryonic expression of Igsf8, an immunoglobulin superfamily member implicated in development of the nervous system and organ epithelia. Mol Cell Neurosci 22, 62-74.
30. Olsen JV, Nielsen PA, Andersen JR, Mann M, and Wisniewski JR (2007). Quantitative proteomic profiling of membrane proteins from the mouse brain cortex, hippocampus, and cerebellum using the HysTag reagent: mapping of neurotransmitter receptors and ion channels. Brain Res 1134, 95-106.
31. Yamada O, Tamura K, Yagihara H, Isotani M, Washizu T, and Bonkobara M (2006). Neuronal expression of keratinocyte-associated transmembrane protein-4, KCT-4, in mouse brain and its up-regulation by neurite outgrowth of Neuro-2a cells. Neurosci Lett 392, 226-230.
32. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, and Berens ME (2007). Molecular targets of glioma invasion. Cell Mol Life Sci 64, 458-478.
33. Belkaid A, Fortier S, Cao J, and Annabi B (2007). Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision. Neoplasia 9, 332-340.
34. Lakka SS, Gondi CS, and Rao JS (2005). Proteases and glioma angiogenesis. Brain Pathol 15, 327-341.
35. Tysnes BB and Mahesparan R (2001). Biological mechanisms of glioma invasion and potential therapeutic targets. J Neurooncol 53, 129-147.
36. Seiki M (1999). Membrane-type matrix metalloproteinases. APMIS 107, 137-143.
37. Thiel G, Lozanova T, Vogel S, Kintzel D, Janisch W, and Witkowski R (1993). Age-related nonrandom chromosomal abnormalities in human low-grade astrocytomas. Hum Genet 91, 547-550.
38. Rickert CH, Strater R, Kaatsch P, Wassmann H, Jurgens H, Dockhorn-Dworniczak B, and Paulus W (2001). Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 158, 1525-1532.
39. Ohgaki H (2005). Genetic pathways to glioblastomas. Neuropathology 25, 1-7.
40. Huang KC, Altinoz M, Wosik K, Larochelle N, Koty Z, Zhu L, Holland PC, and Nalbantoglu J (2005). Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: requirement for the C-terminal domain. Int J Cancer 113, 738-745.
41. Gutmann DH, Maher EA, and Van Dyke T (2006). Mouse models of human cancers consortium workshop on nervous system tumors. Cancer Res 66, 10-13.
42. Candolfi M, Curtin JF, Nichols WS, Muhammad AG, King GD, Pluhar GE, McNiel EA, Ohlfest JR, Freese AB, Moore PF, et al. (2007). Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol 85, 133-148.
43. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C, and Rubinstein E (2001). The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276, 14329-14337.
44. Clark KL, Zeng Z, Langford AL, Bowen SM, and Todd SC (2001). Pgrl is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins. J Immunol 167, 5115-5121.
45. Stipp CS, Orlicky D, and Hemler ME (2001). FPRP: a major, highly stoichiometric, highly specific CD81 and CD9-associated protein. J Biol Chem 276, 4853-4862.
46. Runge KE, Evans JE, He ZY, Gupta S, McDonald KL, Stahlberg H, Primakoff P, and Myles DG (2007). Oocyte CD9 is enriched on the microvillar membrane and required for normal microvillar shape and distribution. Dev Biol 304, 317-325.
47. Zhang XA, Bontrager AL, and Hemler ME (2001). TM4SF proteins associate with activated PKC and link PKC to specific beta1 integrins. J Biol Chem 276, 25005-25013.
48. Yauch RL and Hemler ME (2000). Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphatidylinositol 4-kinase. Biochem J 351, 629-637.
49. 1 integrin. Cancer Lett 103, 201-208.
50. Kohno M, Hasegawa H, Miyake M, Yamamoto T, and Fujita S (2002). CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 97, 336-343.
51. Scrideli CA, Carlotti CG Jr, Okamoto OK, Andrade VS, Cortez MA, Motta FJ, Lucio-Eterovic AK, Neder L, Rosemberg S, Oba-Shinjo SM, et al. (2008). Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol 88, 281-291.
52. Marko NF, Toms SA, Barnett GH, and Weil R (2008). Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study. Genomics 91, 395-406.
53. Nakada M, Okada Y, and Yamashita J (2003). The role of matrix metalloproteinases in glioma invasion. Front Biosci 8, e261-e269.
54. Hotary K, Li XY, Allen E, Stevens SL, and Weiss SJ (2006). A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 20, 2673-2686.
55. Yanez-Mo M, Barreiro O, Gonzalo P, Batista A, Megias D, Genis L, Sachs N, Sala-Valdes M, Alonso MA, Montoya MC, et al. (2008). MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. Blood 112, 3217-3226.
56. Huang CL, Liu D, Masuya D, Kameyama K, Nakashima T, Yokomise H, Ueno M, and Miyake M (2004). MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 23, 7475-7483.
57. Ovalle S, Gutierrez-Lopez MD, Olmo N, Turnay J, Lizarbe MA, Majano P, Molina-Jimenez F, Lopez-Cabrera M, Yanez-Mo M, Sanchez-Madrid F, et al. (2007). The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells. Int J Cancer 121, 2140-2152.
58. Miyake M, Nakano K, Ieki Y, Adachi M, Huang C-L, Itoi S, Koh T, and Taki T (1995). Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 55, 4127-4131.
59. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173.